POLISH PSYCHIATRIC ASSOCIATION BOARD INFORMATION regarding Latuda and Rxulti reimbursement description of indications POLISH PSYCHIATRIC ASSOCIATION BOARD INFORMATION regarding Brintellix reimbursement description of indications
Psychiatria Polska · 2024
DOI: 10.12740/pp/193652 ↗Kurz gefasst
Leserbrief in der Zeitschrift Psychiatria Polska, 2024. Verfasst von Dominika Dudek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Polskie Towarzystwo Psychiatryczne. Hauptthemen laut MEDLINE: Psychiatry. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
bez streszczenia
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Polskie Towarzystwo Psychiatryczne.
Zitieren
APA
Dudek, D., & Mielimąka, M. (2024). POLISH PSYCHIATRIC ASSOCIATION BOARD INFORMATION regarding Latuda and Rxulti reimbursement description of indications POLISH PSYCHIATRIC ASSOCIATION BOARD INFORMATION regarding Brintellix reimbursement description of indications. Psychiatria Polska. https://doi.org/10.12740/pp/193652
Vancouver
Dudek D, Mielimąka M. POLISH PSYCHIATRIC ASSOCIATION BOARD INFORMATION regarding Latuda and Rxulti reimbursement description of indications POLISH PSYCHIATRIC ASSOCIATION BOARD INFORMATION regarding Brintellix reimbursement description of indications. Psychiatria Polska. 2024. doi:10.12740/pp/193652
BibTeX
@article{Dudek2024,
author = {Dudek, Dominika and Mielimąka, Michał},
title = {POLISH PSYCHIATRIC ASSOCIATION BOARD INFORMATION regarding Latuda and Rxulti reimbursement description of indications POLISH PSYCHIATRIC ASSOCIATION BOARD INFORMATION regarding Brintellix reimbursement description of indications},
journal = {Psychiatria Polska},
year = {2024},
doi = {10.12740/pp/193652}
}
EUVIMED